Impact of GLP-1 receptor agonists on stroke, subarachnoid hemorrhage, and intracerebral hemorrhage: a propensity-matched multi-institutional cohort study
Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S (2016) Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and Meta-analysis
The actigraph uses a validated algorithm to translate the presence of movement accelerations into the variables of interest ( 2.5 Statistical analyses The primary outcomes studied were changes in the activity index and number of arousals per night
Still relatively new
A new generation of oral tablets, multi-target agonists, and next-generation injectables is reshaping the competitive landscape at pace, with fresh regulatory approvals, pivotal Phase 3 data, and an expanding list of indications that stretches far beyond weight loss and type 2 diabetes
Nature 546 , 259264 (2017)